SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001062993-18-000271
Filing Date
2018-01-22
Accepted
2018-01-22 17:14:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G sc13g_enzn.htm SC 13G 24983
  Complete submission text file 0001062993-18-000271.txt   26795
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Subject) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-35587 | Film No.: 18540519
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2945 S CENTER GREEN CT G215 BOULDER CO 80301
Business Address 2945 S CENTER GREEN CT G215 BOULDER CO 80301 404-451-7432
HARPER ASSET MANAGEMENT LLC (Filed by) CIK: 0001586910 (see all company filings)

IRS No.: 582648461 | State of Incorp.: GA | Fiscal Year End: 1231
Type: SC 13G